A detailed history of Cubist Systematic Strategies, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 16,042 shares of CLSD stock, worth $14,919. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,042
Holding current value
$14,919
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.93 - $1.35 $14,919 - $21,656
16,042 New
16,042 $20,000
Q1 2024

May 15, 2024

BUY
$1.2 - $2.02 $29,484 - $49,631
24,570 New
24,570 $37,000
Q2 2022

Aug 15, 2022

SELL
$1.3 - $2.49 $24,960 - $47,808
-19,200 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.35 - $2.88 $45,558 - $97,191
-33,747 Reduced 63.74%
19,200 $44,000
Q4 2021

Feb 14, 2022

SELL
$2.72 - $5.72 $73,494 - $154,554
-27,020 Reduced 33.79%
52,947 $146,000
Q3 2021

Nov 15, 2021

BUY
$4.83 - $7.2 $257,492 - $383,839
53,311 Added 200.0%
79,967 $480,000
Q2 2021

Aug 16, 2021

BUY
$2.32 - $5.38 $14,049 - $32,581
6,056 Added 29.4%
26,656 $130,000
Q1 2021

May 17, 2021

BUY
$2.24 - $4.25 $46,144 - $87,550
20,600 New
20,600 $51,000
Q4 2018

Feb 14, 2019

SELL
$1.0 - $6.12 $8,599 - $52,625
-8,599 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$6.03 - $11.24 $49,439 - $92,156
8,199 Added 2049.75%
8,599 $53,000
Q2 2018

Aug 14, 2018

SELL
$8.91 - $14.54 $105,770 - $172,604
-11,871 Reduced 96.74%
400 $4,000
Q1 2018

May 15, 2018

BUY
$5.57 - $14.28 $68,349 - $175,229
12,271 New
12,271 $132,000

Others Institutions Holding CLSD

About Clearside Biomedical, Inc.


  • Ticker CLSD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,190,700
  • Market Cap $56M
  • Description
  • Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...
More about CLSD
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.